Brief: China Biotech Services Holdings Expects Significant Net Loss For 2019
28/02/2020 13:28
Feb 28 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* EXPECTED TO RECORD A SIGNIFICANT NET LOSS FOR 2019 YEAR
* EXPECTED RESULT DUE TO DECREASE IN FY GROSS PROFIT DUE TO
INCREASE IN RAW MATERIAL, STAFF COSTS
Source text for Eikon: ID:nHKS8cS5mG
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)